MaaT Pharma Presents Updated Positive Data for Xervyteg® in Acute Graft-versus-Host Disease at EHA Congress 1 year ago AnaIn Clinical TrialsInnovationPharma Industry Updates
Amneal Pharmaceuticals Secures FDA Approval for Prednisolone Acetate Ophthalmic Suspension 1% 1 year ago AnaIn Clinical TrialsFDA ApprovalsPharma Industry UpdatesResearch Updates
Innovative Biotech Collaborations and Cutting-Edge Clinical Data Spotlight June 11 Advances 1 year ago AnaIn Clinical TrialsIndustry ConferencesInnovationPartnershipsPharma Industry UpdatesResearch Updates
Biotech Innovation and Clinical Advancements Define Mid-June as Industry Gears Up for Breakthroughs 1 year ago AnaIn Clinical TrialsIndustry ConferencesInnovationPharma Industry UpdatesResearch Updates
Merck Gains FDA Approval for ENFLONSIA™ (clesrovimab) to Prevent RSV in Infants; George Medicines’ GMRx2 and AbbVie’s Mavyret Receive Label Expansions 1 year ago AnaIn Clinical TrialsFDA ApprovalsInnovationPharma Industry Updates
June Biotech Momentum: Innovation, Regulatory Shifts, and Strategic Collaborations 1 year ago AnaIn Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
June Pharma Highlights: Vaccine Panel Shake-up, Moderna Deal Fallout, and FDA’s AI Adoption 1 year ago AnaIn Featured AnalysisInnovationLeadersPharma Industry Updates
Cell and Gene Therapy Advances Highlighted in Recent Trials and Industry Collaborations 1 year ago AnaIn Clinical TrialsInnovationPartnershipsPharma Industry UpdatesResearch Updates
ATOMIC Trial Demonstrates Immunotherapy Adds Survival Benefit in Stage III Colon Cancer with dMMR 1 year ago AnaIn Breaking NewsClinical TrialsTop Stories
New Biotech M&A, Radiopharma Advances, and Global Partnerships Shape Early June Momentum 1 year ago AnaIn Clinical TrialsFunding RoundsInnovationPartnershipsPharma Industry UpdatesResearch Updates
SERENA-6 Trial Shifts Strategy in Breast Cancer by Detecting Resistance Earliest via Liquid Biopsy 1 year ago AnaIn Clinical TrialsInnovationPharma Industry Updates
Major Biotech M&A and Global Partnerships Drive Mid-Year Industry Realignment 1 year ago AnaIn DealsInnovationLeadersPartnershipsPharma Industry UpdatesResearch Updates
Shorter Immunotherapy in Late-Stage Melanoma Shows Near-Equivalent Control in UK Phase III Trial 1 year ago AnaIn Breaking NewsClinical Trials
Darolutamide Gains FDA Approval for Metastatic Prostate Cancer; TRexBio and Spinogenix Advance Early-Stage Therapeutics 1 year ago AnaIn Clinical TrialsFDA ApprovalsIndustry ConferencesInnovation
New Trial Shows Promising Benefit from Triple-Drug Regimen in PIK3CA-Mutated HR-Positive, HER2-Negative Breast Cancer 1 year ago AnaIn StartupsTop Stories
